We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Data Deletions Draw Warning for Hebei Yuxing Bio-Engineering
Data Deletions Draw Warning for Hebei Yuxing Bio-Engineering
Hebei Yuxing Bio-Engineering, a Chinese producer of active pharmaceutical ingredients, has significant cGMP and data integrity issues at its manufacturing plant, the FDA said in a warning letter.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor